Skip to content
Production_Salo_2024_1920x1080-7.jpg

Medicines and self-care products

Orion has a wide range of primary healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. Our portfolio consists of a range of hundreds of products.

Orion's own proprietary drugs

Human pharmaceuticals developed by Orion:

  • Nubeqa® (darolutamide), launched 2019
  • dexdor® (dexmedetomidine), 2011
  • Stalevo® (levodopa, karbidopa, entacapone), 2003
  • Simdax® (levosimendan), 2000
  • Precedex® (dexmedetomidine), 1999
  • Comtess®/Comtan® (entacapone), 1998
  • Fareston® (toremifene), 1988

Orion’s discoveries also include the Easyhaler® metered-dose dry powder inhaler for treatment of asthma and chronic obstructive pulmonary disease. The medicines used in Easyhaler devices are generic.

  • Salmeterol/fluticasone Easyhaler® (salmeterol, fluticasone), launched 2018
  • Budesonide/formoterol Easyhaler® (budesonide, formoterol), 2014
  • Formoterol Easyhaler® (formoterol), 2004
  • Budesonide Easyhaler® (budesonide), 2002
  • Beclomet Easyhaler® (beclomethasone), 1994
  • Buventol Easyhaler® (salbutamol), 1993

Orion’s own proprietary products also include animal health products. More information on these products can be found here.

Generic drugs and self-care products

Orion has a very wide portfolio of generic medicines and self-care products. Self-care products include for example, non-prescription medicines, vitamins and skincare products.

In Finland, links to the package leaflets and summaries of product characteristics can be found on the Finnish Medicines Agency Fimea's website.